Wellcome

Novel therapeutic approaches for gastrointestinal malignancies (Record no. 553203)

MARC details
000 -LEADER
fixed length control field 04504nam a22005655i 4500
001 -
control field 978-981-15-5471-1
003 -
control field DE-He213
005 -
control field 20211012192248.0
007 -
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201001s2020 si | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789811554711
-- 978-981-15-5471-1
024 7# -
-- 10.1007/978-981-15-5471-1
-- doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
-- RC261-271
072 #7 -
-- MJCL
-- bicssc
-- MED062000
-- bisacsh
-- MJCL
-- thema
082 04 -
Classification number 614.5999
-- 23
245 10 - TITLE STATEMENT
Title Novel therapeutic approaches for gastrointestinal malignancies
Statement of responsibility, etc edited by Ganji Purnachandra Nagaraju, Sujatha Peela.
250 ## - EDITION STATEMENT
Edition statement 1st ed. 2020.
300 ## - PHYSICAL DESCRIPTION
Extent XII, 259 p. 53 illus., 39 illus. in color.
Other physical details online resource.
505 0# -
Formatted contents note Chapter 1. Role of selected transcription factors in pancreatic and colorectal cancer growth and metastasis -- Chapter 2. Adiponectin in gastrointestinal malignancies -- Chapter 3. Small molecule-targeted therapies for GI cancers: success and failures -- Chapter 4. Epigenetic biomarkers for the detection of Gastrointestinal Cancers -- Chapter 5. CD151: A Lateral organizer and modulator of Tumor microenvironment in gastrointestinal cancers -- Chapter 6. Targeting Pathways in GI Malignancies -- Chapter 7. Identification of Potential Key Genes Involved In Progression of Gastric Cancer Using Bioinformatics Analysis -- Chapter 8. Recent Development in the biomarkers for the gastric cancer -- Chapter 9. Gastric Cancer and it's remedy -- Chapter 10. An intergenic variant rs4779584 between SCG5 and GREM1 contributes to the increased risk of colorectal cancer: A meta-analysis -- Chapter 11. Phytochemicals plus nanomaterial's on colorectal cancer -- Chapter 12. Pancreatic Ductal Adenocarcinoma and Type 2 Diabetes Mellitus: Distant Relatives or the Close Ones? -- Chapter 13. Tumor Biomarkers and Diagnosis of Pancreatic Adenocarcinoma -- Chapter 14. Immunotherapy in Gastrointestinal Malignancies -- Chapter 15. The Role of HIF-1α in Hepatocellular Carcinoma.
650 #0 -
Topical term or geographic name as entry element Cancer research.
Topical term or geographic name as entry element Nanotechnology.
Topical term or geographic name as entry element Radiology.
Topical term or geographic name as entry element Gene expression.
Topical term or geographic name as entry element Cancer Research.
Topical term or geographic name as entry element Nanotechnology.
Topical term or geographic name as entry element Diagnostic Radiology.
Topical term or geographic name as entry element Gene Expression.
700 1# -
Personal name Nagaraju, Ganji Purnachandra.
Relator term editor.
Personal name Peela, Sujatha.
Relator term editor.
710 2# -
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
856 40 -
Uniform Resource Identifier https://doi.org/10.1007/978-981-15-5471-1
245 10 - TITLE STATEMENT
-- [electronic resource] /
264 #1 -
-- Singapore :
-- Springer Singapore :
-- Imprint: Springer,
-- 2020.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
490 1# -
-- Diagnostics and Therapeutic Advances in GI Malignancies,
-- 2662-2696
520 ## -
-- This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to chemoresistance. Further, it discusses the latest trends in the use of small-molecule targeted therapies and immunotherapies as single agents or combination with other treatments. Since resistance to radiation and chemotherapy contribute to the high recurrence and poor survival rates, improving the outcome for GI malignancies is dependent on the introduction of new biomarkers and therapeutic agents. Lastly, the book systematically investigates novel theranostics approaches using nanotechnology for the detection, diagnosis, and personalized treatment of GI malignancies.
-- https://scigraph.springernature.com/ontologies/product-market-codes/B11001
-- https://scigraph.springernature.com/ontologies/product-market-codes/Z14000
-- https://scigraph.springernature.com/ontologies/product-market-codes/H29013
-- https://scigraph.springernature.com/ontologies/product-market-codes/B12010
700 1# -
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
773 0# -
-- Springer Nature eBook
776 08 -
-- Printed edition:
-- 9789811554704
-- Printed edition:
-- 9789811554728
-- Printed edition:
-- 9789811554735
830 #0 -
-- Diagnostics and Therapeutic Advances in GI Malignancies,
-- 2662-2696
912 ## -
-- ZDB-2-SBL
-- ZDB-2-SXB
950 ## -
-- Biomedical and Life Sciences (SpringerNature-11642)
-- Biomedical and Life Sciences (R0) (SpringerNature-43708)
Holdings
Withdrawn status Lost status Damaged status Home library Current library Date acquired Total Checkouts Date last seen Koha item type
      Mysore University Main Library Mysore University Main Library 12/10/2021   12/10/2021 Ebooks

No. of hits (from 9th Mar 12) :

Powered by Koha